Showing all 8 results
Agomelatine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the API.
Active Ingredient Strength Primary Clinical Function Agomelatine USP/Ph.Eur. 25 mg The Therapeutic Anchor: The globally validated dose for restoring circadian rhythm and treating major depression. Excipients Proprietary Matrix Bio-Synchronized Release: Engineered to ensure a rapid $T_{max}$ (approx. 1-2 hours) to align with the body’s natural melatonin surge. Alprazolam & Sertraline Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Sertraline (as HCl) USP/BP 25 mg / 50 mg The Antidepressant Anchor: Provides long-term correction of serotonin levels to treat depression and OCD. Alprazolam USP/BP 0.25 mg / 0.5 mg The Anxiolytic Bridge: Provides rapid relief from acute anxiety and prevents panic spikes. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid release of Alprazolam for immediate relief while Sertraline maintains steady-state plasma levels. Amisulpride Tablets
FreeProduct Composition & Strength
We supply this product in a full range of strengths to facilitate both low-dose “Disthymia” protocols and high-dose “Schizophrenia” maintenance.
Active Ingredient Strength Primary Clinical Function Amisulpride USP/BP 50 mg / 100 mg The Negative Symptom Unit: Used to treat social withdrawal, depression, and lack of initiative. Amisulpride USP/BP 200 mg The Transition Anchor: Used for moderate psychosis or as a step-up dose during titration. Amisulpride USP/BP 400 mg The Positive Symptom Payload: High-potency dose for acute psychotic episodes and hallucinations. Amitriptyline & Chlordiazepoxide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Amitriptyline (as HCl) USP/BP 12.5 mg / 25 mg The Antidepressant Anchor: Elevates mood and energy levels by modulating neurotransmitter reuptake. Chlordiazepoxide USP/BP 5 mg / 10 mg The Anxiolytic Shield: Provides rapid relief from nervousness, agitation, and muscle tension. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid onset of the anxiolytic effect while the antidepressant effect builds over time. Amoxapine Tablets
FreeProduct Composition & Strength
We supply this product in a full range of strengths to allow for precise clinical titration, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amoxapine USP/BP 25 mg / 50 mg The Titration Unit: Used for gradual dose escalation to minimize initial sedative effects. Amoxapine USP/BP 100 mg The Standard Anchor: The primary maintenance dose for outpatients with moderate depression. Amoxapine USP/BP 150 mg The High-Potency Payload: For hospitalized patients with severe psychotic or endogenous depression. Aripipralzole Tablets
FreeProduct Composition & Strength
We supply this product in a wide range of strengths to allow for precise clinical titration, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Aripiprazole USP/Ph.Eur. 2 mg / 5 mg The Titration/Adjunct Unit: Used for initial dosing or as an add-on for Major Depressive Disorder. Aripiprazole USP/Ph.Eur. 10 mg / 15 mg The Standard Anchor: The primary maintenance dose for Schizophrenia and Bipolar Disorder. Aripiprazole USP/Ph.Eur. 20 mg / 30 mg The High-Potency Payload: For acute manic episodes or treatment-resistant cases under specialist care Buprenorphine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed Sublingual Tablet, engineered for rapid mucosal absorption.
Active Ingredient Strength Primary Clinical Function Buprenorphine HCl USP/Ph.Eur. 0.4 mg / 2 mg The Pain & Induction Anchor: Low-dose format for chronic pain or the initial phase of addiction treatment. Buprenorphine HCl USP/Ph.Eur. 8 mg The Maintenance Payload: High-strength dose for long-term stabilization in Opioid Use Disorder. Excipients Sublingual Matrix Rapid Dissolution System: Engineered to dissolve completely under the tongue in < 2 minutes for maximum transmucosal bioavailability. Bupropion tablets
FreeProduct Composition & Strength
We supply this product in three distinct Release Profiles, packed in moisture-resistant Alu-Alu or HDPE containers to protect the stability of the hydrochloride salt.
Release Profile Strength Primary Clinical Function Bupropion XL (Extended Release) 150 mg / 300 mg The Depression Anchor: Once-daily dosing (24-hour release) for MDD and Seasonal Affective Disorder. Bupropion SR (Sustained Release) 150 mg The Smoking Cessation Specialist: Twice-daily dosing (12-hour release) for smoking cessation and MDD. Bupropion IR (Immediate Release) 75 mg / 100 mg The Titration Unit: Immediate-release format for precise dose escalation under specialist supervision.
